Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThere is no licensed oral tirzepatide for weight management available in the UK. Tirzepatide is currently approved here only as Mounjaro, a once-weekly injection. If you have seen references to oral tirzepatide, they most likely describe either overseas trials or unapproved compounded products sold outside the regulated UK pharmacy system. The cost question, then, is really about the legitimate injectable form — and understanding what a fair private price genuinely covers is the more useful calculation to make. Tirzepatide is a prescription-only medicine under UK law, which means a qualified prescriber must assess your suitability before any supply can lawfully happen. Price cannot be the first question; clinical fit has to be.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Oral tirzepatide is in clinical development, and trial data have attracted genuine interest. But as of mid-2026, the MHRA has not licensed any oral tirzepatide product for weight management in the UK. What IS licensed and available privately is Mounjaro, the injectable tirzepatide KwikPen, approved by the MHRA for weight management in adults with a BMI of 30 or above, or 27 or above with at least one weight-related health condition. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance.
It is worth knowing that the oral GLP-1 space in the UK did move in summer 2026: the MHRA approved oral semaglutide tablets (Wegovy tablets) as the first oral GLP-1 medicine licensed for weight management in this country, as detailed on the NHS semaglutide page. That is a different active ingredient. If you are weighing up injectable versus oral options for weight management, our prescribers can walk through what is actually licensed and appropriate for you, but the starting point is a consultation, not a price comparison.
A question our prescribers hear most weeks is whether there is a cheaper oral alternative that does the same job. Honest answer: the injectable form remains the only licensed tirzepatide route in the UK, and cost comparisons with unlicensed products carry risks well beyond the financial ones.
Private Mounjaro pricing in the UK is set per pen, where each pen delivers four weekly doses. Since Eli Lilly raised its UK list price from 1 September 2025, typical private costs across providers have ranged roughly £149 to £375 per month depending on dose and supplier, as widely reported at the time of the change. The lowest dose (2.5mg) carries a lower cost; the highest licensed dose (15mg) sits at the top of that range. You can find a detailed look at how dose affects pricing on our tirzepatide cost page.
What moves the real-world price beyond that headline figure is everything else the provider either includes or bills separately. Some services charge for the initial consultation. Others add a prescription fee. Delivery (especially tracked, next-working-day delivery) is frequently charged on top. Ongoing clinical support, dose-change reviews and repeat prescriptions can each attract separate fees. None of that appears in the per-pen number. A headline price that looks modest often excludes several of those items, which is worth checking before you commit. Patients sourcing treatment from other markets, such as those researching what tirzepatide costs in New Zealand, will find the pricing structures and licensed products differ considerably from the UK picture.
The full Mounjaro pricing picture covers how those components add up across the titration schedule, because the dose you start on is rarely the dose you stay on.
At nume, a single price covers the consultation, the prescription, the medicine, delivery and aftercare. There is no consultation fee on top, no prescription charge added at checkout, no delivery cost to absorb. We do not run subscription plans or auto-renewals: every repeat order is re-reviewed clinically before it is processed. Current treatment pricing is shown on our treatment page, not buried in a checkout flow.
We are not positioned as the cheapest option, deliberately. The infrastructure behind a safe supply (MHRA-regulated dispensing, photo-ID and live video weight verification, Summary Care Record checks where appropriate, a GPhC-registered Independent Prescriber reading every consultation the same day) costs real money to run properly. Cheapest is not a race we entered. What we can say clearly is that nothing is hidden.
If you want to understand what different doses cost as treatment progresses, our 15mg cost page and 5mg cost page break down those points in the titration schedule specifically. For patients moving up through the schedule, it is also worth reading about what the 10mg dose costs, as that mid-titration stage is where many people spend the longest time.
Mounjaro is a Prescription-Only Medicine. That legal status exists for clinical reasons: it interacts with other medicines, it has a specific titration schedule, it requires monitoring, and it is not appropriate for everyone. The MHRA has warned publicly about counterfeit injectable weight-loss pens sold online and via social media, some fake pens have contained insulin, and the enforcement picture grew significantly more serious through 2025. You can verify any online pharmacy on the GPhC register before ordering; sellers offering tirzepatide without a formal clinical assessment should be treated as a serious red flag, not a bargain.
The right metric is not the smallest monthly outlay. It is whether the medicine is genuine, whether it comes from the licensed UK supply chain, whether a real clinician has judged it appropriate for you, and whether support is available when you need it. Our about us page sets out the clinical infrastructure we operate under, and our clinical team are the people whose names sit behind every prescription we issue. If you have questions before starting, our support team is available seven days a week. When you are ready to take the next step, the place to begin is a free clinical consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.